Status:
COMPLETED
Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease
Lead Sponsor:
Association HGE CHU Bordeaux Sud
Conditions:
Liver Fibrosis
Eligibility:
All Genders
18-90 years
Brief Summary
The aim of this prospective study was to compare the 5-year prognostic value of transient elastography (TE), FibroTest (FT), APRI , FIB-4, Lok, and Child-Pugh scores for predicting survival and compli...
Detailed Description
A total of 1616 patients with chronic hepatitis C was included. At 5 years, 79 patients were dead (39 liver-related deaths) and 16 patients had liver transplantation. Overall survival was 91.7% and su...
Eligibility Criteria
Inclusion
- chronic hepatitis C
- chronic hepatitis B
- alcoholic liver disease
- non alcoholic steatohepatitis
Exclusion
- ascitis
Key Trial Info
Start Date :
April 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
1830 Patients enrolled
Trial Details
Trial ID
NCT01241227
Start Date
April 1 2003
End Date
February 1 2009
Last Update
July 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation de la Fibrose hépatique Service Hepato-Gastroentérologie Hopital Haut-Leveque
Pessac, France, 33200